College of Chemical Engineering, Huaqiao University, Xiamen, 361021, China.
College of Chemical Engineering, Huaqiao University, Xiamen, 361021, China.
Carbohydr Polym. 2021 Jun 1;261:117847. doi: 10.1016/j.carbpol.2021.117847. Epub 2021 Feb 26.
Surface functionalization of mesoporous silica nanoparticles (MSNs) has been proposed as an efficient strategy for enhancing the biocompatibility and efficiency of an MSN-based carrier platform. Herein, natural polyelectrolyte multilayers composed of poly-l-ornithine (PLO) and carboxymethyl lentinan (LC) were coated on the surface of MSNs through a layer-by-layer (LbL) self-assembly technique, and were characterized by ζ-potential, FTIR, C NMR, SEM, TEM, XRD, and TG. The prepared carrier presented alternating positive and negative potentials when coated with the polyelectrolytes, and the surface of MSN-PLO/LC was rougher compared to the naked MSNs. The biocompatibility tests, including cytocompatibility, hemocompatibility, and histocompatibility, showed that MSNs biocompatibility could be improved by modifying LC. A high loading and sustained release drug delivery system was constructed after loading doxorubicin (DOX) into the prepared MSN-PLO/LC, which exhibited significant anti-proliferative efficiency in human cervical cancer cell lines (Hela). Therefore, the PLO/LC LbL NPs (layer-by-layer self-assembled nanoparticles coated with PLO/LC layers) based on MSNs, which is easily prepared by electrostatic interactions, can be considered a promising drug chemotherapeutic platform and delivery technique for future human cervical cancer therapy.
介孔硅纳米粒子(MSNs)的表面功能化被提出作为增强基于 MSN 的载体平台的生物相容性和效率的有效策略。在此,通过层层(LbL)自组装技术将由聚-l-鸟氨酸(PLO)和羧甲基香菇多糖(LC)组成的天然聚电解质多层涂覆在 MSNs 的表面上,并通过 ζ-电位、FTIR、C NMR、SEM、TEM、XRD 和 TG 进行了表征。当用聚电解质涂覆时,制备的载体呈现出交替的正电和负电,并且 MSN-PLO/LC 的表面比裸 MSNs 更粗糙。包括细胞相容性、血液相容性和组织相容性在内的生物相容性测试表明,通过修饰 LC 可以提高 MSNs 的生物相容性。将阿霉素(DOX)载入制备的 MSN-PLO/LC 后,构建了高载药量和持续释放的药物输送系统,在人宫颈癌细胞系(Hela)中显示出显著的抗增殖效率。因此,基于 MSNs 的 PLO/LC LbL NPs(用 PLO/LC 层涂覆的层层自组装纳米颗粒)可以通过静电相互作用轻松制备,可被认为是未来人类宫颈癌治疗的有前途的药物化疗平台和输送技术。